Skip to content

Drug interactions

Glycopyrronium + Umeclidinium bromide

Severity: Moderate

Glycopyrronium and Umeclidinium bromide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both agents block muscarinic receptors, and glycopyrronium given orally or parenterally is absorbed systemically and may add to the effects of inhaled umeclidinium. This raises the risk of dry mouth, urinary retention, constipation, tachycardia and narrow-angle glaucoma worsening.

What this interaction means in plain words

Glycopyrronium and Umeclidinium bromide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Additive muscarinic receptor antagonism.

What to do

Avoid concurrent use of multiple antimuscarinics where possible. Monitor for urinary retention, raised intraocular pressure and constipation.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glycopyrronium and Umeclidinium bromide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Glycopyrronium with Umeclidinium bromide?

MediHelp rates the interaction as moderate. Glycopyrronium and Umeclidinium bromide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both agents block muscarinic receptors, and glycopyrronium given orally or parenterally is absorbed systemically and may add to the effects of inhaled umeclidinium. This raises the risk of dry mouth, urinary retention, constipation, tachycardia and narrow-angle glaucoma worsening.

How serious is the interaction between Glycopyrronium and Umeclidinium bromide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use of multiple antimuscarinics where possible. Monitor for urinary retention, raised intraocular pressure and constipation.

What other medicines interact with Glycopyrronium?

MediHelp also lists interactions of Glycopyrronium with, for example, Clozapine, Abobotulinumtoxina, Aclidinium. The full list is on the Glycopyrronium page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in